A detailed history of Nicholas Investment Partners, LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 65,360 shares of PRCT stock, worth $5.81 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
65,360
Previous 76,232 14.26%
Holding current value
$5.81 Million
Previous $4.66 Million 12.41%
% of portfolio
0.58%
Previous 0.55%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$56.31 - $84.99 $612,202 - $924,011
-10,872 Reduced 14.26%
65,360 $5.24 Million
Q2 2024

Aug 07, 2024

BUY
$45.73 - $69.19 $3.49 Million - $5.27 Million
76,232 New
76,232 $4.66 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.97B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.